Robert ‘Bob’ Ingram, a pillar of Triangle’s life science industry, dies
Robert “Bob” Ingram, one of the most important leaders in the North Carolina life science industry and a former CEO of GlaxoWellcome (now GSK), has died.
Read MorePosted by WRAL TechWire | Mar 29, 2023
Robert “Bob” Ingram, one of the most important leaders in the North Carolina life science industry and a former CEO of GlaxoWellcome (now GSK), has died.
Read MorePosted by WRAL TechWire | Feb 8, 2022
Amgen and Chief Executive Officer Robert A. Bradway, former Glaxo Wellcome CEO Robert A. Ingram, and B&C Associates Inc. Founder and CEO Robert J. Brown were recently recognized today for their leadership and collaboration to fight cancer through innovative research and health and well-being programs.
Read MorePosted by WRAL News | Sep 29, 2020
Ingram is general partner at Durham-based Hatteras Venture Partners, the region’s leading investor in early stage life sciences companies. He also serves as board chairman of Durham-based BioCryst Pharmaceuticals, and is a board member of Novan, and of HBM Healthcare Investments.
Read More